EHA2016_PressBrief_Fr_03Daratumumab shows remarkable benefit in relapsed or refractory multiple myeloma in the pollux study

Press brief by Meletios Dimopoulos, MD of the University of Athens, Athens, Greece, at the 2016 Annual Meeting of the European Association of Hematology (EHA), held in Copenhagen, Denmark.